e-learning
resources
Madrid 2019
Monday, 30.09.2019
Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
C- Reactive protein Kinetic in the Prognosis of Ventilator-Associated Pneumonia
S. Pothal (Sambalpur, India), C. Shit (Sambalpur, India), P. Dutta (Sambalpur, India), R. Manjhi (Sambalpur, India), A. Behera (Sambalpur, India)
Source:
International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Session:
Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Session type:
Thematic Poster
Number:
2264
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Pothal (Sambalpur, India), C. Shit (Sambalpur, India), P. Dutta (Sambalpur, India), R. Manjhi (Sambalpur, India), A. Behera (Sambalpur, India). C- Reactive protein Kinetic in the Prognosis of Ventilator-Associated Pneumonia. 2264
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
Viral Sepsis in Adults with Community-Acquired Pneumonia
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
Time to Blood Culture Positivity as a Predictor of Clinical Outcomes and Severity in Adults with Bacteremic Pneumococcal Pneumonia
Source: International Congress 2017 – Update on community acquired pneumonia
Year: 2017
Community-Acquired Pneumonia with Evolving Cavitation and Peripheral Eosinophilia
Source: International Congress 2018 – CC8 Non-resolving pneumonia
Year: 2018
Meta-analysis of Acute Coronary Syndrome in Patients with Community-Acquired Pneumonia
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020
Risk Factors and Clinical Impact of Fibrotic-Like Changes and the Organizing Pneumonia Pattern in Patients with COVID-19- and Non-COVID-19-induced Acute Respiratory Distress Syndrome.
Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure
Year: 2021
Twenty-year Trend in Mortality among Hospitalized Patients with Pneumococcal Community-Acquired Pneumonia
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
Peculiarities of Immune Status among Young Patients with Community-Acquired Pneumonia (CAP) during Cytomegaloviral Persistence (CMVP)
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Ventilator-Induced Lung Injury Increases Systemic Inflammation in Murine Pseudomonas Aeruginosa Pneumonia
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019
Community-Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV-Infected Adult Patients: A Matched Case-Control Study
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021
Molecular Markers of Telomere Dysfunction and Senescence are Common Findings in the Usual Interstitial Pneumonia Pattern of Lung Fibrosis
Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias
Year: 2018
Unrevealed Structural, Functional and Immunological Pulmonary Changes Induced by Metabolic Syndrome in Elderly
Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Year: 2020
Differential Expression of Plasma Metabolites in Patients with Pulmonary Sarcoidosis is Associated with Clinical Behavior
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018
Consequences of SARS-COV-2 Pneumonia on Lung function
Source: Virtual Congress 2021 – Emerging evidence on sub-acute and long COVID-19
Year: 2021
Early Prediction of Extubation Failure in Severe Pneumonia: A Retrospective Cohort Study
Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine
Year: 2019
Characterization of the Immune Response in Clinical Sepsis To Identify Potential Therapeutic Targets
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020
Applying Modern Molecular Microbiological Techniques to Identify Treatable Chronic Bacterial Airway Infection in Severe Asthma
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020
Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Clinical Features and Treatment Outcome of Carcinomatous Pericarditis due to Lung Cancer.
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Year: 2018
Is there an Optimal Door-to-Treatment Time for Acute Pulmonary Embolism? A National Propensity Match Analysis
Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept